It has been reported that people with schizophrenia who are ho
mozygous at the c.267C>A single nucleotide poly
morphis
m of the cholinergic
muscarinic M1 receptor (
m>CHRM1m>) perfor
m less well on the Wisconsin Card Sorting Test than those who are heterozygous. We investigated whether
m>CHRM1m> sequence is associated with i
mpaired executive function, a co
mmon proble
m in schizophrenia.
We sequenced the m>CHRM1m> using peripheral DNA from 97 people with schizophrenia who completed the Wisconsin Card Sorting Test, a verbal fluency test and the National Adult Reading Test. Clinical severity was assessed using the Positive and Negative Syndrome Scale. To determine whether m>CHRM1m> sequence affected receptor expression, we used post-mortem data, from another cohort, to investigate associations between m>CHRM1m> sequence and mRNA levels.
On the Wisconsin Card Sorting Test, 267C/C participants with schizophrenia made more perseverative errors (m>pm> < 0.05) and perseverative responses (m>pm> < 0.05) than 267C/A participants. Genotype had no effect on verbal fluency (m>pm> = 0.8) or National Adult Reading test (m>pm> = 0.62). Cortical m>CHRM1m> mRNA levels did not vary with gene sequence (m>pm> = 0.409).
The clinical study supports the proposal that m>CHRM1m> sequence is associated with alterations in some aspects of executive function. However, the post-mortem study indicates this is not simply due to altered expression at the level of mRNA, suggesting this sequence alteration may affect the functionality of the CHRM1.